my learning log

where I write about stuff I’ve learnt

22/8/2024: Stop SGLT2-inhibitors in acutely unwell patients (especially if there’s a risk that they could develop DKA). SGLT2-inhibitors can result in euglycaemic ketosis because they allow urinary loss of glucose, starving cells of glucose, and making them use up fatty acids, resulting in production of ketones.